載入...
Calcineurin inhibitors revisited: A new paradigm for COVID-19?
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can cause mild, moderate or severe disease (COVID-19). In severe disease, there is hyperinflammation causing severe symptoms. Severe COVID-19 is an immunological phenomenon, rather than a direct viral damage disease. Therapies for COVI...
Na minha lista:
| 發表在: | Braz J Infect Dis |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7320855/ https://ncbi.nlm.nih.gov/pubmed/32603679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bjid.2020.06.005 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|